
Avocado Pharmaceuticals Private Limited
Pharmaceutical company specializing in distribution, marketing, and research of medicines and healthcare products.
Pharmaceutical company specializing in distribution, marketing, and research of medicines and healthcare products.
Avocado Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 December 2009 and has a history of 15 years and two months. Its registered office is in Ernad, Kerala, India.
The Corporate was formerly known as Avacado Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 0.96 M.
The company has closed loans amounting to ₹2.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sumesh Gangadharan, Suresh Pillai, and Kunukkara Manoj serve as directors at the Company.
Ernad, Kerala, India
+91-XXXXXXXXXX
-
U51397KL2009PTC025181
025181
Private Limited Indian Non-Government Company
18 Dec 2009
30 Sep 2023
31 Mar 2023
Unlisted
Roc Ernakulam
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kunukkara Manoj ![]() | Managing Director | 01-Feb-2010 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sumesh Gangadharan ![]() | Director | 05-Feb-2013 | Current |
Suresh Pillai ![]() | Director | 05-Feb-2013 | Current |
Avocado Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.59% increase. The company also saw a substantial improvement in profitability, with a 82.48% increase in profit. The company's net worth Soared by an impressive increase of 42.57%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Avocado Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹0
₹2.50 M
Date | Lender | Amount | Status |
---|---|---|---|
09 Feb 2017 | Others | ₹2.50 M | Satisfied |
Unlock and access historical data on people associated with Avocado Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Avocado Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avocado Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Avocado Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Avocado Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam.
A charge registered on 09 Feb 2017 via Charge ID 100107067 with Others was fully satisfied on 14 Mar 2023.
A charge with Others amounted to Rs. 2.50 M with Charge ID 100107067 was registered on 09 Feb 2017.
Sumesh Gangadharan was appointed as a Director was appointed as a Director on 05 Feb 2013 & has been associated with this company since 12 years 27 days .
Suresh Kumar Gopinatha Pillai was appointed as a Director was appointed as a Director on 05 Feb 2013 & has been associated with this company since 12 years 27 days .
Avocado Pharmaceuticals Private Limited was incorporated on 18 Dec 2009.
The authorized share capital of Avocado Pharmaceuticals Private Limited is ₹ 1.20 M and paid-up capital is ₹ 0.96 M.
Currently 3 directors are associated with Avocado Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Avocado Pharmaceuticals Private Limited is 8/1919-B, Vallanchira Nilabur Road Manjeri Manjeri Bazar, Ernad, Kerala, India, 676121.
The corporate identification number (CIN) of Avocado Pharmaceuticals Private Limited is U51397KL2009PTC025181 and the company number is 025181 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Avocado Pharmaceuticals Private Limited has risen by 49.59%.
The financial reports for the fiscal year 2023 indicates that The net worth of Avocado Pharmaceuticals Private Limited has experienced an upsurge of 42.57%.
The most recent Balance Sheet for Avocado Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
MC
MR
MJ
PV
SR